A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies

Barbara Spitzer; Ann A. Jakubowski; Esperanza B. Papadopoulos; Kirsten Fuller; Patrick D. Hilden; James W. Young; Juliet N. Barker; Guenther Koehne; Miguel-Angel Perales; Katharine C. Hsu; Marcel R. van den Brink; Nancy A. Kernan; Susan E. Prockop; Andromachi Scaradavou; Hugo Castro-Malaspina; Richard J. O'Reilly; Farid Boulad

doi:10.1016/j.bbmt.2017.07.004

A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies

Barbara Spitzer, Ann A. Jakubowski, Esperanza B. Papadopoulos, Kirsten Fuller, Patrick D. Hilden, James W. Young, Juliet N. Barker, Guenther Koehne, Miguel-Angel Perales, Katharine C. Hsu, Marcel R. van den Brink, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Hugo Castro-Malaspina, Richard J. O'Reilly, Farid Boulad

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Biology of Blood and Marrow Transplantation
Volume	23
DOIs	https://doi.org/10.1016/j.bbmt.2017.07.004
State	Published - Jan 12 2017

Disciplines

Medicine and Health Sciences
Endocrinology, Diabetes, and Metabolism
Immunology and Infectious Disease

Access to Document

10.1016/j.bbmt.2017.07.004License: Unspecified

Cite this

Spitzer, B., Jakubowski, A. A., Papadopoulos, E. B., Fuller, K., Hilden, P. D., Young, J. W., Barker, J. N., Koehne, G., Perales, M.-A., Hsu, K. C., van den Brink, M. R., Kernan, N. A., Prockop, S. E., Scaradavou, A., Castro-Malaspina, H., O'Reilly, R. J., & Boulad, F. (2017). A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of Blood and Marrow Transplantation, 23. https://doi.org/10.1016/j.bbmt.2017.07.004

A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. / Spitzer, Barbara; Jakubowski, Ann A.; Papadopoulos, Esperanza B. et al.
In: Biology of Blood and Marrow Transplantation, Vol. 23, 12.01.2017.

Research output: Contribution to journal › Article › peer-review

Spitzer, B, Jakubowski, AA, Papadopoulos, EB, Fuller, K, Hilden, PD, Young, JW, Barker, JN, Koehne, G, Perales, M-A, Hsu, KC, van den Brink, MR, Kernan, NA, Prockop, SE, Scaradavou, A, Castro-Malaspina, H, O'Reilly, RJ & Boulad, F 2017, 'A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies', Biology of Blood and Marrow Transplantation, vol. 23. https://doi.org/10.1016/j.bbmt.2017.07.004

Spitzer B, Jakubowski AA, Papadopoulos EB, Fuller K, Hilden PD, Young JW et al. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of Blood and Marrow Transplantation. 2017 Jan 12;23. doi: 10.1016/j.bbmt.2017.07.004

@article{37c1b1b808a84fb4a8feb747b5c17a80,

title = "A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies",

author = "Barbara Spitzer and Jakubowski, \{Ann A.\} and Papadopoulos, \{Esperanza B.\} and Kirsten Fuller and Hilden, \{Patrick D.\} and Young, \{James W.\} and Barker, \{Juliet N.\} and Guenther Koehne and Miguel-Angel Perales and Hsu, \{Katharine C.\} and \{van den Brink\}, \{Marcel R.\} and Kernan, \{Nancy A.\} and Prockop, \{Susan E.\} and Andromachi Scaradavou and Hugo Castro-Malaspina and O'Reilly, \{Richard J.\} and Farid Boulad",

note = "We sought to develop a myeloablative chemotherapeutic regimen to secure consistent engraftment of T-cell depleted (TCD) hematopoietic stem cell transplantations (HSCT) without the need for total body irradiation, thereby reducing toxicity while maintaining low rates of graft-versus-host disease (GVHD) and without increasing relapse.",

year = "2017",

month = jan,

day = "12",

doi = "10.1016/j.bbmt.2017.07.004",

language = "American English",

volume = "23",

journal = "Biology of Blood and Marrow Transplantation",

}

TY - JOUR

T1 - A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies

AU - Spitzer, Barbara

AU - Jakubowski, Ann A.

AU - Papadopoulos, Esperanza B.

AU - Fuller, Kirsten

AU - Hilden, Patrick D.

AU - Young, James W.

AU - Barker, Juliet N.

AU - Koehne, Guenther

AU - Perales, Miguel-Angel

AU - Hsu, Katharine C.

AU - van den Brink, Marcel R.

AU - Kernan, Nancy A.

AU - Prockop, Susan E.

AU - Scaradavou, Andromachi

AU - Castro-Malaspina, Hugo

AU - O'Reilly, Richard J.

AU - Boulad, Farid

N1 - We sought to develop a myeloablative chemotherapeutic regimen to secure consistent engraftment of T-cell depleted (TCD) hematopoietic stem cell transplantations (HSCT) without the need for total body irradiation, thereby reducing toxicity while maintaining low rates of graft-versus-host disease (GVHD) and without increasing relapse.

PY - 2017/1/12

Y1 - 2017/1/12

UR - https://www.sciencedirect.com/science/article/pii/S1083879117305736

U2 - 10.1016/j.bbmt.2017.07.004

DO - 10.1016/j.bbmt.2017.07.004

M3 - Article

VL - 23

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

ER -

A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies

Disciplines

Access to Document

Other files and links

Cite this